PLYMOUTH, Minn.--(BUSINESS WIRE)--ev3 Inc. (NASDAQ:EVVV), a global endovascular device company, today announced preliminary net sales of approximately $92.2 million for the fourth quarter of 2007, a 60% increase over net sales of $57.7 million in the comparable quarter of 2006. The company’s guidance for fourth quarter 2007 net sales was $108 million or greater. As a result of fourth quarter performance, ev3 has also revised its 2008 net sales guidance to $500 million or greater and revised 2008 earnings guidance as described below in “Outlook.”
